BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tarao K, Tanaka K, Nozaki A, Sato A, Ishii T, Komatsu H, Ikeda T, Komatsu T, Matsushima S, Oshige K. Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients. World J Hepatol 2017; 9(11): 544-550 [PMID: 28469810 DOI: 10.4254/wjh.v9.i11.544]
URL: https://www.wjgnet.com/1948-5182/full/v9/i11/544.htm
Number Citing Articles
1
Shimaa Kamel, Hagar Elessawy, Ossama Ashraf, Ahmed Elbaz, Hany Dabbous, Manal El-Sayed, Safaa Ali, Heba Kamel. Effectiveness of Direct-Acting Antivirals in Treatment of Elderly Egyptian Chronic Hepatitis C PatientsGastroenterology Insights 2021; 12(3): 336 doi: 10.3390/gastroent12030031
2
F. Ji, B. Wei, Y. H. Yeo, E. Ogawa, B. Zou, C. D. Stave, Z. Li, S. Dang, N. Furusyo, R. C. Cheung, M. H. Nguyen. Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in AsiaAlimentary Pharmacology & Therapeutics 2018; 47(5): 550 doi: 10.1111/apt.14507
3
Fumitaka Suzuki, Naoya Hatanaka, Etsuya Bando, Koji Nakamura, Akira Komoto. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in JapanHepatology International 2018; 12(3): 244 doi: 10.1007/s12072-018-9872-z
4
Rosanna Villani, Matteo Monami, Francesca Di Cosimo, Gilda Fioravanti, Edoardo Mannucci, Gianluigi Vendemiale, Gaetano Serviddio. Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysisJournal of Viral Hepatitis 2019; 26(11): 1249 doi: 10.1111/jvh.13169
5
Efficacy and Safety of Daclatasvir and Asunaprevir Combination Therapy in Elderly Chronic Hepatitis C PatientsJournal of Korean Society of Health-System Pharmacists 2018; 35(4): 453 doi: 10.32429/jkshp.2018.35.4.007
6
Yoshinori Ozono, Kenji Nagata, Satoru Hasuike, Hisayoshi Iwakiri, Kenichi Nakamura, Mai Tsuchimochi, Yuri Yamada, Yuka Takaishi, Mitsue Sueta, Tadashi Miike, Yoshihiro Tahara, Shojiro Yamamoto, Kotaro Shide, Tomonori Hidaka, Yoko Kubuki, Kazunori Kusumoto, Toshimasa Ochiai, Junya Kato, Naoto Komada, Shuichi Hirono, Kazuo Kuroki, Masafumi Shigehira, Kazuya Shimoda. Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1World Journal of Hepatology 2017; 9(36): 1340-1345 doi: 10.4254/wjh.v9.i36.1340
7
Tanner Wright, Yalong Wang, Mark T. Bedford. The Role of the PRMT5–SND1 Axis in Hepatocellular CarcinomaEpigenomes 2021; 5(1): 2 doi: 10.3390/epigenomes5010002